Francois Ferre, Ph.D.
- Dr. Ferre is a Sr. Fund Advisor with Mesa Verde and Member of the Investment Committee. Dr. Ferre is co-Chairman of the Board and co-founder of Althea Dx, Inc., a San Diego company developing and commercializing diagnostic tests for the personalized medicine. He is also a co-founder and former co-Chief Executive Officer of Althea Technologies, Inc, a San Diego company that provides services and technologies to streamline drug development. Dr. Ferre has over twenty years of experience in cancer research and HIV clinical development and has held management positions at Cytometrics and The Immune Response Corporation. Dr. Ferre is a leader in gene quantification and biomarker development with over twenty years of experience in the field. He has published several authoritative reviews on the topic of gene quantification, co-edited a bestseller book on PCR with Dr. Kary Mullis and Dr. Richard Gibbs, and edited a book on the topic of gene quantification. Dr. Ferre received his Ph.D. in Molecular Oncology from the Pasteur Institute in Lille, France and did his post-doctoral training at the University of California, San Diego. Dr. Ferre was the winner of the 2005 E&Y Entrepreneur of the Year award in the Life Sciences category and is a co-founder and Managing Member of Alma Life Sciences, L.L.C., a small San Diego early stage venture fund.